Aspirin + vitamin c

Generic Medicine Info
Gastric or duodenal ulcers. Haemophilia, thrombocytopenia or other bleeding tendencies; patients receiving anti-coagulant treatment. Hypersensitivity to aspirin or other salicylates or ascorbic acid. Severe renal impairment.
Special Precautions
Risk of Reye's syndrome in children with varicella infection or influenza-like illnesses. Not to be used for >10 days without medical advice. Treatment should be withdrawn 1 wk prior to surgery to prevent or reduce risk of bleeding complications. Caution when used in patients with impaired renal function, severe hepatic impairment, history of GI disorders e.g. peptic ulcers, ulcerative colitis and Crohn's disease, dyspepsia and when the patient is dehydrated. Pregnancy and lactation.
Adverse Reactions
Dizziness, GI irritation e.g. dyspepsia, nausea, vomiting, erosion, ulceration, haematemesis and melaena. Prolonged use of high doses of aspirin may cause anaemia, blood dyscrasia, GI haemorrhage and peptic ulceration.
Drug Interactions
Aspirin may increase hypoprothrombinemic effect of warfarin and other oral anticoagulants, thus increasing the risk of bleeding complications. May antagonise uricosuric effect of probenecid, phenylbutazone or sulfinpyrazone. Concurrent admin with corticosteroids may reduce the serum levels of aspirin. Aspirin may increase serum levels of methotrexate. Concurrent admin with alcohol increases risk and severity of GI bleeding and ulceration. Aspirin may reduce the absorption of vitamin C.
ATC Classification
S01XA15 - ascorbic acid ; Belongs to the class of other ophthalmologicals.
G01AD03 - ascorbic acid ; Belongs to the class of organic acid antiinfectives. Used in the treatment of gynecological infections.
Disclaimer: This information is independently developed by CIMS based on aspirin + vitamin c from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in